Harvard Diabetes Comorbidities And Complications 2024 (Videos With Captions + Slides)

Comprehensive Updates for State-of-the-Art Diagnosis, Management, and Prevention
Diabetes Comorbidities and Complications will be held online, using live streaming, electronic Q&A, and other remote learning technologies.
This comprehensive course provides education and updates to optimize your care of patients with diabetes and these conditions:

Obesity
Cardiovascular Disease
Heart Failure
Coronary Artery Disease
Cerebrovascular Disease
Hypertension
Hyperglycemia
Hypoglycemia
Dyslipidemia
Metabolic-Associated Fatty Liver Disease
Chronic Kidney Disease

Sessions are led by experts in these conditions and their impact on the patient with diabetes. Faculty deliver practical education that is focused on:

Advancing your knowledge of diabetes comorbidities and complications
Delivering state-of-the-art approaches to evaluation and management of the patient with diabetes and these conditions
Identifying practical strategies to reduce the risk of diabetes comorbidities and complications
Optimizing clinical decision-making
Improving patient outcomes

In addition to their clinical expertise, faculty have been chosen for their inspirational teaching skills and their ability to provide specific recommendations to incorporate the vast number of recent updates covered in this program into day-to-day clinical practice.
EDUCATIONAL HIGHLIGHTS
This program provides strategies, updates, and new practice recommendations to improve your care of patients with (and at risk for) diabetes complications and comorbidities. Participants can rely on this program for updates that ensure state-of-the-art:

PREVENTION and RISK REDUCTION
DIAGNOSIS
MANAGEMENT
USE of the NEWEST DIABETES DRUGS, TECHNOLOGIES, and DEVICES

PREVENTION and RISK REDUCTION

New algorithms for evaluating cardiovascular and renal risk in patients with diabetes
Medical treatment and lifestyle interventions to prevent:

Cardiovascular disease
Kidney disease
Cerebrovascular disease
Hyper- and hypoglycemia

Medication interactions: avoiding adverse outcomes
Impact of the newest pharmacological tools to reduce CV and renal disease development and progression

DIAGNOSIS
Expanded options for diagnosis of:

Coronary artery disease
Heart failure
Cerebrovascular disease
Chronic kidney disease
Metabolic-associated fatty liver disease
Hypoglycemia

MANAGEMENT

Adjusting pharmacological therapies in the patient with diabetes complications
Evaluating, managing, and monitoring diabetic CKD
Obesity management: when to consider new therapeutic and surgical options
Diagnosis and management of coronary artery disease in the patient with diabetes
Management of kidney disease in the patient with diabetes
Hypertension and cholesterol management: customizing targets and treatment strategies for each patient
Heart failure: improving patient functional capacity with combined therapies
Management of cerebrovascular disease
Updates in the management of hyper- and hypoglycemia
Current guidelines for treating metabolic-associated fatty liver disease
Combining innovative therapeutic combinations with traditional approaches
Strategies to assess and manage interacting comorbidities

INCORPORATING NEW DRUGS, TECHNOLOGIES, and DEVICES INTO PRACTICE
The expanded roles of SGLT-2 inhibitors, MRA, and GLP-1 RA in treating CV and renal disease
Practical recommendations for the use of GLP-1 RA, SGLT-2 inhibitors, and MRA
Advances in glucose monitors, insulin pumps, and diabetes apps
SOCIAL, RACIAL, SEXUAL, and CULTURAL DIFFERENCES IN DIABETES CARE NEEDS
We are committed to offering the best practices for health care equity and the needs of diverse patient populations. Highlights include:
Management of diabetes and related disorders in diverse racial/ethnic populations
Recognizing biases: strategies for achieving equity and addressing disparities
Establishing and maintaining connections with patients